Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstrom's Macroglobulinemia”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Testing effectiveness (Phase 2)Study completedNCT00004889
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00113802
What this trial is testing

Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Gilead Sciences 31
Testing effectiveness (Phase 2)Study completedNCT04463953
What this trial is testing

Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Ended earlyNCT00265928
What this trial is testing

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Virginia 46
Early research (Phase 1)Ended earlyNCT01078974
What this trial is testing

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Steven P. Treon, MD, PhD 7
Early research (Phase 1)Ended earlyNCT00060294
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02381080
What this trial is testing

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLC 26
Testing effectiveness (Phase 2)Study completedNCT00083707
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
University of Arkansas 40
Large-scale testing (Phase 3)UnknownNCT02991638
What this trial is testing

Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-cell LymphomasChronic Hepatitis B+4 more
The University of Hong Kong 62
Testing effectiveness (Phase 2)Study completedNCT00146055
What this trial is testing

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

Who this might be right for
Myeloma, Plasma-CellLymphoma, MalignantMyeloproliferative Disorders+2 more
University of Michigan Rogel Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT02400437
What this trial is testing

Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00936611
What this trial is testing

LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 39
Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Testing effectiveness (Phase 2)UnknownNCT02971982
What this trial is testing

PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Treatment
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Study completedNCT01046006
What this trial is testing

Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Meletios A. Dimopoulos 59
Testing effectiveness (Phase 2)Study completedNCT00003416
What this trial is testing

S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
SWOG Cancer Research Network 9
Early research (Phase 1)Study completedNCT04274738
What this trial is testing

Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4

Who this might be right for
Waldenstrom's Macroglobulinemia
X4 Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT04062448
What this trial is testing

Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)

Who this might be right for
Waldenstrom Macroglobulinemia
Janssen Pharmaceutical K.K. 16
Early research (Phase 1)Ended earlyNCT01744912
What this trial is testing

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Who this might be right for
Non-Hodgkins LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+4 more
TG Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Looking for participantsNCT03697356
What this trial is testing

R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
Kosin University Gospel Hospital 54
Load More Results